CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $544,900 | +22.4% | 20,000 | 0.0% | 0.01% | +22.2% |
| Q2 2023 | $445,000 | +2.7% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $433,200 | +6.6% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $406,200 | -20.8% | 20,000 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $513,000 | +7.8% | 20,000 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $476,000 | -3.8% | 20,000 | -9.1% | 0.01% | +11.1% |
| Q1 2022 | $495,000 | +25.6% | 22,000 | +10.0% | 0.01% | +28.6% |
| Q3 2021 | $394,000 | -10.5% | 20,000 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $440,000 | +340.0% | 20,000 | 0.0% | 0.01% | +166.7% |
| Q4 2015 | $100,000 | +33.3% | 20,000 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $75,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,003,723 | $95,164,000 | 6.41% |
| TANAKA CAPITAL MANAGEMENT INC | 65,609 | $780,000 | 3.41% |
| S&T BANK/PA | 588,620 | $6,999,000 | 1.93% |
| Parallel Advisors, LLC | 1,405,895 | $16,716,000 | 1.35% |
| Matarin Capital Management, LLC | 623,915 | $7,418,000 | 1.15% |
| AJ WEALTH STRATEGIES, LLC | 668,020 | $7,943,000 | 1.08% |
| Capital Impact Advisors, LLC | 177,300 | $2,108,000 | 0.88% |
| Alambic Investment Management, L.P. | 29,547 | $351,000 | 0.85% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 332,436 | $3,953,000 | 0.79% |
| Spark Investment Management LLC | 116,400 | $1,383,000 | 0.74% |